Press Release

Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results

November 3, 2017 at 8:00 AM EDT

CAMBRIDGE, Mass., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, November 7, 2017, at 5:00 p.m. ET to discuss a corporate update and results for the third quarter of 2017.

To access the call, please dial 844-348-3801 (domestic) or 213-358-0955 (international) and provide the passcode 9487629. A live webcast of the presentation will be available on the Investors & Media section of the Editas website at

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact
Cristi Barnett
Editas Medicine, Inc.
(617) 401-0113

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083



Source: Editas Medicine, Inc.